ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,555, issued on Feb. 24, was assigned to IMMUNE-ONC THERAPEUTICS INC..
"Anti-LILRB4 antibodies and derivative products" was invented by An Song (Palo Alto, Calif.), Tao Huang (Mountain View, Calif.), Ryan Stafford (Foster City, Calif.), Maria Jose Costa (Palo Alto, Calif.), Kyu Hee Hong (Palo Alto, Calif.), Caroline Bonnans (San Francisco), Jianhui Zhou (Redwood City, Calif.), Li Zhou (San Jose, Calif.), Ji Li (Foster City, Calif.), J. Paul Woodard (Palo Alto, Calif.) and X. Charlene Liao (Palo Alto, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides anti-LILRB4 antibodies or antigen-binding fragments thereof, anti-...